Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential clinical benefit of prophylactic
cytomegalovirus (CMV)-specific adoptive cellular therapy following T cell depleted allogeneic
hematopoietic stem cell transplantation (HSCT) for reducing recurrent CMV reactivation.